BioNTech founders Professor Uğur Şahin, M.D. and Professor Özlem Türeci, M.D., in an exclusive conversation with UNSW Provost, Professor Vlado Perkovic, discuss how to translate science into survival by combining fundamental research and operational excellence to develop new immunotherapies.

Together with its partner Pfizer, BioNTech led the global COVID-19 vaccine effort with the successful development of the first approved mRNA vaccine, known today as the Pfizer-BioNTech COVID-19 vaccine.

But, what’s next? 

Can mRNA technology change individualised cancer medicine or cure infectious disease? How can scientists evaluate next generation diagnostics and medicines? What type of ecosystem will enable next generation clinical trials at scale? Is it possible to accelerate access to precision medicine for Australians who need it? Hear how these global leaders want to improve the health of people worldwide and their efforts to make it a reality.  

Presented by UNSW Medicine & Health.

See omnystudio.com/listener for privacy information.